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ABSTRACT
A limited number of Methicillin-resistant
Staphylococcus aureus (MRSA) clones are respon-
sible for MRSA infections worldwide, and those of
different lineages carry unique Type I restriction-
modification (RM) variants. We have identified the
specific DNA sequence targets for the dominant
MRSA lineages CC1, CC5, CC8 and ST239. We
experimentally demonstrate that this RM system is
sufficient to block horizontal gene transfer between
clinically important MRSA, confirming the bioinfor-
matic evidence that each lineage is evolving inde-
pendently. Target sites are distributed randomly
in S. aureus genomes, except in a set of large
conjugative plasmids encoding resistance genes
that show evidence of spreading between two suc-
cessful MRSA lineages. This analysis of the identifi-
cation and distribution of target sites explains
evolutionary patterns in a pathogenic bacterium.
We show that a lack of specific target sites
enables plasmids to evade the Type I RM system
thereby contributing to the evolution of increasingly
resistant community and hospital MRSA.
INTRODUCTION
Staphylococcus aureus is a common pathogenic bacterium
particularly noted for its acquisition of resistance to anti-
biotics. The worldwide problem of Methicillin-resistant
(MRSA) strains is now not only conﬁned to hospitals
but is also increasing in the wider community owing to
the emergence of new clones such as S. aureus USA300
(1–3). Staphylococcus aureus is the leading cause of
bacterial infections involving the bloodstream, lower re-
spiratory tract and skin and soft tissue in many developed
countries, including the USA (4).
Approximately 10 lineages of S. aureus dominate in
humans and isolates of the same lineage exchange DNA
at higher frequency than isolates belonging to different
lineages (5). This may explain the observation from bio-
informatic studies that the distribution of mobile genetic
elements (MGEs) such as plasmids and bacteriophage is lin-
eage dependent (6–8) and suggests each lineage is evolving
relatively independently.As theseMGEs encodemanyviru-
lence and resistance genes, the lack of gene exchange
between the dominant MRSA lineages has likely delayed
the evolution of new clones (1).WhenMRSAclones acquire
new MGEs, they can colonize new niches and host groups.
Recently, this has resulted in hospital-associated MRSA,
community-associated MRSA and livestock-associated
MRSA clones that pose signiﬁcant new challenges for
healthcare and agriculture (1).
Despite its notoriety, S. aureus is actually a difﬁcult
organism to transform; therefore, the acquisition of
MGEs encoding antibiotic resistance is, perhaps fortu-
nately for its hosts, a rather slow process. This low efﬁ-
ciency of horizontal gene transfer is due in part to the
presence of DNA restriction and modiﬁcation (RM)
systems on the S. aureus genome such as the Type I RM
system (given the generic name of Sau1) in which the
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modiﬁcation methyltransferase (MTase) sustains the
methylation of deﬁned target recognition sequences
(TRS) on host DNA and the restriction endonuclease
cleaves foreign DNA containing unmethylated copies of
the TRS (9).
Of note was the discovery that the Sau1 systems found in
strains of S. aureus, correlated perfectly with the lineages
(and Clonal Complex or ‘CC’ groups) into which S. aureus
strains are divided (5,10). The Sau1 systems, encoded by the
genes ‘host speciﬁcity for DNA’ (hsd), have conserved
Restriction (R) subunits and conserved Modiﬁcation (M)
subunits, but the Sequence speciﬁcity (S) subunits vary de-
pending on the CC group (Figure 1A). Each lineage or CC
group typically has a single hsdR gene distant from two
copies of the hsdM and hsdS genes (Table 1 shows the
genes and genome coordinates for the systems studied in
this work). The genes for Type I RM systems usually
comprise an hsdR gene with its own promoter and a
separate promoter for the hsdM and hsdS genes, the open
reading frames of which usually overlap by a small number
of nucleotides (Figure 1B). This organization is observed
for the Sau1 Type I RM systems (5,10,11,15). The R
subunits and the M subunits are 99% identical between
different CC groups (Supplementary Figures S1 and S2),
thus allowing a single R subunit to function with each pair
of M and S subunits. They show considerable homology to
the R and M subunits of the EcoR124I Type I RM system,
although the level of identity is too low to indicate that the
Sau1 RM systems are in the same Type IC family as
EcoR124I but instead form their own family
(Supplementary Figures S3 and S4). Not only are the two
pairs of hsdM-hsdS genes distant from the hsdR gene, they
are also distant from each other on the chromosome
(Figure 1A and Table 1) and lie in two genomic islands
(5,10,11). This collection of ﬁve genes allows each lineage
to recognize two different TRS (Figure 1B), but why the
hsdR gene has come to be so distant from the other genes is
not clear. Lactococcus lactis also shows separation of the
Type I RM genes with extra copies of different hsdS lying
on plasmids complementing the hsdR, hsdM and hsdS genes
on the chromosome (16).
S subunits are of mosaic structure with two target rec-
ognition domains (TRDs) ﬂanked by highly conserved
amino acid sequences (Figure 1B and Supplementary
Figure 1. The hsdR, hsdM and hsdS genes of S. aureus. (A) Genome organization of the RM genes in S. aureus showing the unusual arrangement of
the hsdR gene that is separate from two copies of the hsdMS genes. Genome N315 (CC5) is shown, with restriction genes (hsdR) as red arrows,
modiﬁcation genes (hsdM) as blue arrows and speciﬁcity genes (hsdS) as yellow arrows. The numbers inside the circle refer to the ORF number and
numbers outside the circle are the genome coordinates. Figures derived from whole-genome sequence and information in REBASE (11,12).
(B) Domain structure of the proteins encoded by hsd genes. Each lineage carries a single hsdR gene the product of which carries an N-terminal
domain (brown), a nuclease domain (red), a motor domain (cyan) and a tail domain (pink), which can function with the products of either of the two
copies of the hsdS and hsdM genes. The gene organization for expression of the M and S subunits of a typical Type I RM system features a single
promoter to drive expression, and there is a frameshift at the junction between the two open reading frames. The M subunit contains an N-terminal
domain (green), a catalytic domain (blue) and a C-terminal tail (grey). The S subunit contains conserved regions (cr, orange) around the two TRDs
(various colours). Ribbon cartoon models of each subunit of the EcoR124I Type I RM enzyme (13) with domains coloured as above are also shown.
The EcoR124I amino acid sequences show homology with those of the S. aureus Type I RM enzymes (Supplementary Figures S3 and S4). Each S
subunit in this work has a C-terminal EGFP and hexa-His tag added to allow the MTase to be easily puriﬁed, but this is not shown here for clarity
(14). (C) hsdS gene variant distribution. Each of the S. aureus lineages encode two copies of the hsdS gene that are different from each other in the
TRDs (various colours). Identical hsdS genes conserved between different lineages have matching TRD colours and are shaded. The hsdS variants in
lineages CC8 (which are the same as for ST239) are homologous to one of those carried in lineages CC1 and CC5, respectively. hsdR and hsdM genes
are highly conserved across the lineages.
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Figure S5) (9). The DNA TRS recognized by an S subunit
typically consists of 3 or 4 deﬁned base pairs followed by a
non-speciﬁc spacer of 6 bp followed by a second set of
3–5 deﬁned base pairs. (9) The ﬁrst TRD recognizes the
ﬁrst part of the TRS, the second TRD recognizes the
second part of the TRS and the conserved amino acid
sequence separating the TRDs deﬁnes the length of the
non-speciﬁc spacer in the TRS (9). If TRDs recognize
the same DNA sequence, then they show a high degree
of amino acid identity, but the level of identity is low if
they recognize different sequences (Supplementary Figure
S5). The TRD amino acid sequences all show a bias
towards basic residues resulting in estimated values for
the isoelectric point for the S subunits of between 9.2
and 9.5, as one would anticipate for a DNA-binding
protein (17). The mosaic structure most probably derives
from an ancestral ‘half-S’ gene, which underwent multiple
duplication and recombination events to produce the
range of mosaics observed today. Functional half-S
subunits can be generated experimentally and recognize
symmetrical TRS (18,19). This mosaic structure is not
only obvious in S. aureus (5,11,15) but also in extensive
genome analyses of Mycoplasma pulmonis (20), Neisseria
meningitidis (21), Helicobacter pylori (22) and Bacteroides
fragilis (23). Inversions are also evident allowing phase
variation and the generation of multiple TRS within a
single bacterial population (20,23).
Staphylococcus aureus genomes usually contain two
copies of hsdS that each have a different sequence.
Figure 1C shows the distribution of the hsdS gene
variants, as determined from mosaic structure of their
TRD sequences, in whole-genome sequences of MRSA
from the major lineages CC1, CC8/ST239 and CC5.
Lineage CC8 hsdS genes show strong homology with the
CC5-1 and CC1-2 genes that are found in CC5 and CC1
isolates, respectively. ST239 isolates have evolved from
CC8 isolates and have maintained the same hsdS genes
(5,10). The predicted protein sequence of the CC5-1 S
subunit is 100% conserved over 403 aa between CC5
and CC8 isolates, including representative isolates from
CC5 (S. aureus N315 and Mu50), CC8 (S. aureus 8325,
USA300 FPR3757, Newman and COL) and ST239
(S. aureus TW20). The CC1-2 S subunit is 99% conserved
over the entire 399aa between CC1 and CC8 isolates,
including representative isolates from CC1 (S. aureus
MW2, MSSA476), CC8 (S. aureus 8325, USA300
FPR3757, Newman and COL) and ST398 (S. aureus
TW20). The two amino acid changes are located outside
of the TRDs.
The TRS for Type I RM systems are extremely difﬁcult
to determine because their restriction endonucleases do
not cut DNA at their TRS but at random sequences
distant from the TRS. Their determination has relied on
the comparison of transformation efﬁciency or restriction
of a library of DNA fragments followed by computer
analysis. Methylation occurs at deﬁned positions in the
target site, but ﬁnding the location is difﬁcult, although
single-molecule real-time sequencing methods for the
analysis of whole-genome modiﬁcation patterns are
being developed (24).T
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In this article, we have identiﬁed the speciﬁc DNA
sequence targets for the dominant MRSA lineages CC1,
CC5, CC8 and ST239. Identiﬁcation of the TRS for the
Sau1 Type I RM system and their distribution in S. aureus
genomes allows the understanding and prediction of how
they contribute to the evolution of S. aureus populations.
In particular, the spread of MGEs encoding virulence and
resistance genes is fundamental to the development of
newly evolving MRSA clones and will be dependent on
the TRS they carry. Furthermore, identiﬁcation of TRS
enables strategic design of genetic vectors that can
overcome Type I RM systems and will enable genetic
manipulation of clinically relevant pathogenic strains in
the research laboratory.
MATERIALS AND METHODS
Preparation of enzymes
The hsd genes for the Sau1 MTases (Table 1) were
ampliﬁed from genomic DNA and used to replace the
genes for the EcoKI MTase in the expression plasmid
pJFMSEGFP (14). All four Sau1 MTase operons lacked
BamHI restriction sites in their open reading frames, thus
allowing a common cloning strategy using only one vector.
Following the success of producing EcoKI MTase with the
S subunit tagged with the enhanced green ﬂuorescent
protein (EGFP) and a hexa-Histidine tag from plasmid
pJFMSEGFP (14), we engineered an expression construct
for all four MTases. Through the use of the polymerase
chain reaction (PCR), using oligonucleotides pJFM
SEGFPhisBS (50GAGTGAATCCCCGGGGATCCGTC
GACC 30) and pJFMSEGFPhisTS (50AGTCAGTCAGG
GATCCATGGTGAGCAAGGGCGAGGAGCTG30)
with pJFMSEGFP as template, we obtained a linear PCR
derivative of the vector. The resulting PCR product allows
a coding sequence to be introduced downstream of the tac
promoter and fused in frame with EGFP-His-tag following
digestion of the ends of the coding sequence with BamHI.
The hsdM -hsdS operon was ampliﬁed from the appropri-
ate S. aureus genomic DNA by PCR, using a universal
Sau1M oligonucleotide, (50AGTCAGTCAGGGATCCA
AGAAGGAGATATACATATGTCTATTACTGAAAA
ACAACG30) in every reaction, in combination with a
locus-speciﬁc oligonucleotide, homologous to the end of
the appropriate hsdS as follows:
CC5-1 BS (50GATCGAATTCCGGATCCTAAGAACA
TTTTTTGTAAAAAGG30),
CC5-2 BS (50GATCGAATTCCGGATCCAACAAACA
TTTTTTGTAATAGTTC30),
CC1-1 BS (50GATCGAATTCCGGATCCAATAAACA
TTTTCTGTAAAAACGCC30),
CC1-2 BS (50GATCGAATTCCGGATCCAATAAAC
ATTTTTTGTAATAGTTC30). The resulting PCR
products were puriﬁed, cut with BamHI and ligated into
the BamHI interval of the vector PCR product. The uni-
versal Sau1M oligonucleotide assumes that the M subunit
commences with the sequence MSITEKQRQQQ and
ignores unconserved sequences upstream of the conserved
ATG start codon for methionine. The plasmids were
named pCCX-Y where X is the number of the clonal
complex and Y of the loci. The hsdR gene (Genbank
BAB41410.1) was ampliﬁed from isolate N315 (CC5) by
PCR using oligonucleotides as follows:
Sau1 hsdRFOR (50AAGGAGATATACCATGGCATA
CCAAAGTGAATACGC30) and
Sau1 hsdRREV (50GAATTCGGATCCTTACACACC
GTATTTTTCAGTTG30). The fragment was cut with
NcoI and BamHI and ligated into the NcoI - BamHI
interval of pRSFDuet-1. The DNA sequence of the
chosen clone agreed perfectly with the desired sequence.
The plasmid was named phsdR. In each case, the DNA
sequences of individual clones were conﬁrmed.
Protein expression was induced by adding isopropyl
b-D-1-thiogalactopyranoside to 1mM to transformed
Escherichia coli BL21(DE3) cultures growing at 37C.
Cells containing either the pCCX-Y plasmids expressing
the MTase or cells containing the phsdR were grown. The
MTases and the R subunit were puriﬁed separately.
Induction was for 3–4 h at 25C or 30C. The cells were
disrupted by intermittent sonication for 20min with
cooling on ice using a Soniprep 150 sonicator (Sanyo,
Tokyo, Japan) ﬁtted with a 9mm diameter probe and
then centrifuged at 20 000g for 90min at a temperature
of 4C. Proteins were puriﬁed by HisTrap chromatog-
raphy, size exclusion chromatography, diethylaminoethyl
(DEAE) anion exchange chromatography and, if neces-
sary, Heparin HiTrap chromatography (GE Healthcare,
Uppsala, Sweden) and were >98% pure as judged by
Coomassie Blue staining of SDS–polyacrylamide gels.
The puriﬁed proteins were stored at 20C after
addition of glycerol to 50% (v/v). NaCl was also added
to 0.2M for the CC1-1, CC1-2 and CC5-1 MTase prepar-
ations and to 0.5 M for the CC5-2 MTase and R subunit
preparations to maintain protein solubility. Extinction co-
efﬁcients were calculated at 280 nm (25) and assuming an
M2S1 stoichiometry for the MTases (and including the
EGFP and hexa-His tag on the S subunit) and a mono-
meric R subunit (13,26). The puriﬁed proteins were
analysed by SDS–PAGE and estimated to be >95%
pure (Figure 2). To form an active restriction enzyme,
the MTase preparations were mixed with the R subunit.
Target recognition sites
Endonuclease cleavage assays were performed by
incubating a library of plasmids, based on insertion of
known DNA sequences ligated into the EcoRI-BamHI
interval of pUC19, with MTase and R subunit for
15min at 37C and analysed using agarose gel electro-
phoresis. Cleavage sites are distant from the target site
for these enzymes; therefore, a computer program,
RMsearch, was used to search for target sequences
present in plasmids cut by the enzyme and not present
in uncut plasmids (27,28). The main set of plasmids were
based on the DNA sequence of phage PhiED1 (a kind gift
from Dr Garry Blakely, Edinburgh) as described in
Supplementary Materials and Methods. Also described
in the Supplementary Materials and Methods are sets of
plasmids containing smaller fragments of phage PhiED1
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and inserts from phage lambda (a kind gift from Iain
Murray of New England Biolabs). Typically, 40
plasmids were analysed for each enzyme. Cleavage sites
were then conﬁrmed by inserting a short deﬁned oligo-
nucleotide sequence containing the putative target into
pUC19 (sequences described in Supplementary Materials
and Methods). Reaction digests had a total volume
of 50 ml and a typical digest was prepared using 5 ml of
10NEBuffer 4 [New England Biolabs; 50mM potassium
acetate, 20mM Tris–acetate, 10mM magnesium acetate,
1mM dithiothreitol (pH 7.9)], 2mM ATP, 0.64 mM
S-adenosyl-L-methionine, 0.01mg of bovine serum
albumin and 10 ml of the enzyme stock. The enzyme
stock was prepared in a volume of 50 ml with 5 ml of
10xNEBuffer 4 with ﬁnal concentrations of 1.16 mM R
subunit and 0.42mM MTase, thus ensuring an excess of
R over the MTase to give formation of the R2M2S1 RM
enzyme.
Staphylococcus aureus strains and plasmids
JE2 is a CC8 MRSA and belongs to the USA300 clonal
group. It is plasmid negative, has been derived from strain
LAC and has high genome similarity to FPR3757 (29).
JE2 mutants in hsdS (NE1258, NE982), hsdR (NE667)
and Type IV restriction endonuclease (NE513) were
generated by mariner transposon mutagenesis. All JE2-
derived isolates were obtained from NARSA and are
the original isolates constructed at the University of
Nebraska (31). N315 is a CC5 MRSA (11). The shuttle
vector pCN36 (31) was used in all transfer experiments. It
carries a tetM selectable marker and has two CC5-1 TRS,
one CC1-2 TRS and no CC5-2 TRS.
Electroporation
Plasmid DNA was prepared from S. aureus using Wizard
Plus SV Minipreps DNA Puriﬁcation (Promega, UK)
with an additional lysostaphin (L4402, Sigma-Aldrich,
UK) treatment step and concentration measured by UV
spectrometry. Electroporation was carried out essentially
as described previously (32) and transformants selected on
agar supplemented with tetracycline at 5 mg/ml.
Bioinformatics
TRS distribution was analysed using NCBI Sequence
Viewer 2.21 (http://www.ncbi.nlm.nih.gov/projects/
sviewer/). Annotated S. aureus whole-genomes (n=18)
(7), and the MGEs bacteriophage (n=50) (8),
Staphylococcal Cassette Chromosomes carrying the
mecA gene (n=35) (33) and plasmids (n=233) (6) were
analysed; these genomes and MGEs are listed in
Supplementary Table S1. We manually checked the
whole genome of the representative MRSA252 isolate
and found no evidence that target sites were dismissed
owing to target overlap using this method. Values were
expressed as the average TRS per kb of each type of
genome analysed. Statistical comparison of TRS fre-
quency using the Mann–Witney two-tailed test was
calculated by dividing observed TRS per genome by
expected numbers of TRS per genome (based on whole
genome TRS frequency). Comparing the numbers of
genomes with zero TRS used the chi-square test. TRS
per plasmid was visualized using Excel. Protein extinction
coefﬁcients and isoelectric points were calculated using
http://www.scripps.edu/cdputnam/protcalc.html.
RESULTS
Protein preparation
The puriﬁed proteins were analysed by SDS–PAGE and
estimated to be >95% pure (Figure 2). To form an active
restriction enzyme, the MTase preparations were mixed
with an excess of the R subunit.
Naming of the Sau1 systems
As the putative open reading frames for the Sau1 systems
from CC1 and CC5 have been overexpressed and shown to
be active, they can be assigned formal names according to
the convention (34). These names are given in Table 1 as
Figure 2. SDS–PAGE analysis of puriﬁed proteins. The upper band in
the MTase preparations is the EGFP-His-tagged S subunit and the
lower band is the M subunit. The EcoKI MTase with the EGFP-His-
tagged S subunit is shown for comparison. The puriﬁed R subunit is
also shown. The markers have molecular masses of 250, 150, 100, 75,
50, 37, 25 and 20 kDa (Biorad precision plus protein standards).
The arrows indicate the 75 kDa size.
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SauMW2I, SauMW2II, SauN315I and SauN315II.
However, as these names are speciﬁc to the particular S.
aureus strain rather than to the lineage containing the
strain, they are not useful when trying to determine the
TRS for Type I RM systems shared with other lineages.
The naming difﬁculty is compounded when a single R
subunit from a single strain can be used to complement
the MTases from any other strain. Thus, although the
formal names should be used for descriptions of the indi-
vidual enzymes, it is easier to use names based on the CC
groups when comparing groups of these S. aureus enzymes.
Table 1 also gives our suggested names based on CC
groups, which we will use in the remainder of this article,
these being CC1-1, CC1-2, CC5-1 and CC5-2 for
SauMW2I, SauMW2II, SauN315I and SauN315II, re-
spectively. Using these lineage-based names, the Type I
enzymes are referred to as the CCX-Y MTase for the
M2S1 complex and the CCX-Y RM enzyme for the
mixture of the M2S1 MTase with an excess of the R
subunit to form the R2M2S1 complex. The X refers to the
clonal complex, and the Y refers to the proximity of the
hsdM-hsdS genes to the start of the genome sequence, with
1 indicating genes closer to the ﬁrst nucleotide in the
genome sequence than those labelled 2. This nomenclature
also allows the TRS to be referred to as CCX-Y sequences
or sites.
Endonuclease activity and target recognition site
determination
Escherichia coli was transformed with plasmids expressing
the hsdM and hsdS gene variants and the MTase complex
puriﬁed and combined with puriﬁed R subunit. Figure 3
shows the ability of the RM enzymes to cleave a selection
of plasmids from our library of plasmids and
Supplementary Table S2 summarizes the ability of the
Sau1 RM enzymes to cleave the full library of plasmids.
The plasmid preparations usually showed only supercoiled
closed circular DNA but when incubated with the Sau1
RM enzymes, varying amounts of nicked open circular
DNA were produced even in the absence of ATP. We
attribute this nicking activity to the presence of a small
amount of a contaminating nuclease in our enzyme prep-
arations. The key indicator of cleavage by the Sau1 RM
enzymes is the ATP-dependent production of linearized
DNA if the plasmid contains a single TRS or a smear of
products of different lengths if the plasmid contains
multiple TRS. The smearing occurs because Type I RM
enzymes cleave at random distances from their TRS rather
than at the TRS.
The pUC19 plasmid was not cut by the CC1-1, CC5-1
and CC5-2 RM enzymes; thus, any cleavage of pUC19
containing an inserted fragment of DNA indicated the
presence of a TRS in the insert. A computer comparison
of the sequences of cleavable and uncleavable plasmids
allowed determination of the candidate TRS for these
enzymes. To aid this process, subsets of pUC19 with
shorter and shorter DNA inserts had to be constructed
and lastly conﬁrmation of the proposed TRS was
obtained using a short synthetic oligonucleotide
sequence inserted into pUC19.
The CC1-2 RM enzyme cleaved pUC19 DNA to a
linear form; thus, it has a single TRS for CC1-2. To use
the plasmid library based on pUC19, the DNA was ﬁrst
cut with either BamHI or EcoRI to a linear form.
Subsequent incubation with CC1-2 RM enzyme would
leave the DNA in a linear form if no additional TRS
were present in the DNA, but a smear would result if
the insert had a TRS. This smearing is the result
expected if the linear DNA contains two or more copies
of the TRS. Computer analysis and the pUC19 plasmid
subsets allowed identiﬁcation of the TRS for the CC1-2
RM enzyme.
Table 1 shows the TRS determined for lineages CC1
and CC5. These are typical of target sequences for Type
I RM systems, although that for CC5-1 RM enzyme is one
of the shortest yet found. Our data do not deﬁne which
adenine nucleotides are the target for methylation by the
enzymes, but apart from the sequences TTAA and TGT,
only a single location in each part of the TRS is possible
(i.e CCAY, ATC, CCT, GTA will be methylated at the
underlined positions either on the A shown or on the A on
the complementary strand).
Distribution of target recognition sites in genomes
and plasmids
The distribution of each identiﬁed TRS in sequenced S.
aureus genomes (Figure 4A) revealed a random distribu-
tion of each amongst whole genomes of S. aureus from
various lineages, as well as several MGEs. The exceptions
were plasmids, which speciﬁcally harboured fewer sites for
the CC5-2 RM enzyme and often lacked these sites alto-
gether (Figure 4B). A direct comparison of 233 plasmids
showed that this was not conﬁned to small plasmids,
which might be expected to carry fewer TRS by chance
owing to their small size (Figure 4C). Notably, multiple
large conjugative plasmids, identiﬁed by the carriage of
the tra gene locus for transfer (red), were particularly de-
ﬁcient in the TRS for the CC5-2 RM enzyme (Figure 4C).
We hypothesized that this represents evolution of the
larger plasmids to escape this enzyme and tested this
experimentally.
Transfer of plasmids between lineages
Electroporation of plasmids into S. aureus JE2, a CC8
SCCmecIV USA300 isolate typical of MRSA circulating
in the community in the USA, was controlled by the Type
I RM system (Figure 5). Plasmids grown in S. aureus JE2
donors deﬁcient in each of the two hsdS genes recognizing
the CC5-1 and CC1-2 TRS were not modiﬁed, and when
transferred to parental JE2 recipients, these plasmids were
recognised as foreign and restricted (Figure 5A and B).
Restriction was due to the Type I RM system and hsdR
dependent, as when this gene was deleted the unmodiﬁed
plasmid was transferred at high frequency. Transfer was
not restored by deleting the Type IV restriction system,
showing no role for this system in transfer of plasmids
between the MRSA isolates (although it does prevent
transformation of cytosine-methylated plasmids prepared
from E.coli containing the dcm MTase) (35,36). Similarly,
plasmids grown in S. aureus N315, a clinical MRSA from
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lineage CC5, were recognized as foreign and digested
by the Type I and not the Type IV restriction system
(Figure 5B).
A lack of sites for the CC5-2 RM enzyme in plasmids
is crucial for their successful horizontal transfer from CC8
to CC5, as the second TRS recognized in CC5, namely,
CC5-1, is shared by the lineages and therefore does not
act as a barrier (Figure 5). This was conﬁrmed by electro-
poration of a plasmid carrying TRS for CC1-2 and CC5-1,
but lacking the CC5-2 target sequence (Figure 5). As pre-
dicted, the efﬁciency of transfer from CC5 (N315) to CC8
(JE2 and JE2 Type IV-) was low (mean 10.3 transformants
Figure 3. (A) Agarose gel analysis of DNA cleavage activity of the prepared Sau1 restriction enzymes using plasmids pACYC184 and pET20b.
CC1-1, CC1-2, CC5-1 and CC5-2 indicate the Type I restriction enzyme used. pACYC184 has no site for CC1-1 but multiple sites for the other Type
I enzymes as indicated by the smearing of the cleaved DNA. CC1-1 nicks the plasmid, but this is non-speciﬁc. pET20b has no site for CC5-2 and a
single site for the other Type I enzymes as indicated by the linearization of the plasmid. CC5-2 nicks the plasmid, but this is non-speciﬁc.
(B) Example cleavage assay using the CC5-1 enzyme against the 2 kb CLONE1-20 library and the pY library described in Supplementary
Material. CLONE8, pY361, pY432, pY614, pY696 and pY698 either showed unexpected molecular masses or too many sites resulting in an
uninterpretable smear and were not included in our analyses. M=1 kb markers with the arrow indicating the 3 kb size (New England Biolabs),
uncut indicates the supercoiled plasmid, +RI indicates the plasmid linearized by EcoRI.
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Figure 4. Plasmids have fewer CC5-2 target sites than expected. (A) Average target recognition sites (TRS) per kb for CC5-1, CC5-2 and CC1-2
enzymes in S. aureus sequences of whole-genomes (n=18), plasmid (n=233), bacteriophage (n=50) and Staphylococcal cassette chromosomes with
mecA (n=35). By Mann–Witney two-tailed test, enzyme 5-1 had signiﬁcantly more TRS in plasmids, and SCCmec than genomes (P< 0.01); enzyme
5-2 had signiﬁcantly less TRS in plasmids than genomes (P< 0.0001); enzyme 1-2 had signiﬁcantly less TRS in phage (P< 0.01) but signiﬁcantly
more TRS in SCCmec (P< 0.0001). Asterisk indicates signiﬁcant, P< 0.01, Double asterisk indicates signiﬁcant, P< 0.0001. (B) Percentage of MGEs
lacking target sites for CC5-1, CC5-2 and CC1-2 in sequences of plasmid (n=233), bacteriophage (n=50) and Staphylococcal cassette chromosomes
with mecA (n=35). There are signiﬁcantly more plasmids missing TRS for 5-2 than missing TRS for 5-1 or 1-2 (Chi square, P< 0.0001, indicated by
asterisk) (C) TRS distribution proﬁle of plasmid sequences (n= 233) ordered by size shows small plasmids (<10 kb) are more likely to be missing a
CC5-2 TRS than missing a CC5-1 or CC1-2 TRS (Chi square, P< 0.0001), and that large conjugative plasmids (tra+; indicated by red dash, n=14)
are more likely to have zero CC5-2 TRS than zero CC5-1 or CC1-2 TRS (Chi square, P< 0.001). Each horizontal line represents a plasmid and is
shaded according to the number of TRS.
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Figure 5. Electroporation of plasmid pCN36 is dependent on Sau1 Modiﬁcation and Restriction. (A) Plasmid methylation proﬁles of pCN36 when
grown in different donor backgrounds. There are two TRS for the CC5-1 enzyme (recognized by both CC8 and CC5 isolates), one target site for
CC1-2 (recognized by CC8), and no target sites for CC5-2 (recognized by CC5). CC5-1 and CC1-2 refer to S. aureus JE2 (CC8) isolates with
mutations in sau1hsdSCC5-1 and sau1hsdSCC1-2, respectively. (B) Transformation efﬁciency of pCN36 (tetracycline resistant colonies per 1 mg DNA)
into S. aureus JE2 (CC8) is dependent on modiﬁcation with both CC5-1 and CC1-2 and restriction by sau1hsdR (5,6), but not with restriction by the
Type IV restriction system (35,36). pCN36 prepared from S. aureus N315 (CC5) is not readily accepted by S. aureus JE2 (CC8). (C) Transformation
efﬁciency of pCN36 from S. aureus JE2 (CC8) to S. aureus N315 (CC5) is dependent on CC5-1 modiﬁcation, and not CC5-2. S. aureus N315 (CC5)
accepts plasmid at high rates from S. aureus JE2 (CC8), as pCN36 does not contain a TRS for CC5-2. Data presented represent average trans-
formation efﬁciency of three experiments±SD. Asterisk denotes signiﬁcant difference P< 0.001.
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per mg of plasmid DNA) (Figure 5B), whereas the
efﬁciency of transfer from CC8 to CC5 was high
(mean 22892 transformants per mg of plasmid DNA)
(Figure 5C).
This can be explained by the distribution of TRS sites.
If the plasmid was modiﬁed in the CC8 (JE2) background
by only the CC1-2 system (JE2 CC5-1- donor), then the
CC5-1 TRS were unmodiﬁed, and when transferred to the
CC5 (N315), the plasmid was recognized as foreign and
restricted (Figure 5C). In contrast, if the plasmid was
modiﬁed in the JE2 background by only the CC5-1
system (JE2 CC1-2- donor), the N315 recipient would
recognize the CC5-1 modiﬁed TRS as self, and as there
are no unmodiﬁed targets for the CC5-2 to recognize, the
plasmid transfers successfully (Figure 5C). The results
suggest that when plasmids are missing the CC5-2 target
sites and originate in a CC8 background, CC5 recipients
will not recognize them as foreign, as there is no unmodi-
ﬁed TRS remaining to be recognized. Therefore, large nat-
urally occurring resistance plasmids can transfer easily
from CC8 to CC5, but not the reverse.
Implications of target recognition site identiﬁcation on
MRSA evolution
This study investigated the Type I RM target sites of three
major S. aureus lineages, which are also the parental
lineages of four of the most successful and prevalent
MRSA lineages worldwide (1,2). The CC8 lineage
includes the MRSA clone S. aureus USA300 responsible
for the majority of community-associated (CA-) MRSA in
the USA (3,14), and S. aureus USA500, which is a
common hospital-associated (HA-) MRSA in the USA
and Europe (37). MRSA ST239 clones are the most
common HA-MRSA in Asia and South America and
found worldwide (38). ST239 arose from a recombination
of the CC8 and CC30 lineages, with the resultant clone
carrying the CC8 hsdS genes (39). CC5 clones such as S.
aureus USA100 are the most common HA-MRSA in the
USA and some regions of Europe and Asia (37). The CC1
clone S. aureus USA400 was the original CA-MRSA in
the USA and is still widespread (37).
Examples of large plasmids that do not have CC5-2
target sites include the 37 kb conjugative plasmid
pUSA03 isolated from S. aureus USA300 and encoding
resistance to erythromycin and mupirocin (29). This
plasmid has eleven targets sites for CC5-1, ﬁve for CC1-
2 and none for CC5-2. SAP082A, also from S. aureus
USA300, is a 44 kb conjugative plasmid encoding gen-
tamicin resistance and has 13 target sites for CC5-1,
eight for CC1-2 and none for CC5-2 (40). Similar
plasmids are reported to be carried in CC5 isolates in
the USA (39), suggesting there has been horizontal
transfer of this plasmid group between clinical MRSA
lineages. This is in contrast to the majority of plasmids
that have a distribution correlating with lineage (6). The
data suggest that CC5 isolates in hospitals in the USA and
the new CC8 isolates from the community in the USA,
which are now spreading to hospitals, are exchanging
multi-drug resistance plasmids at higher frequency than
other lineages.
DISCUSSION
Few Type I RM target recognition sites have been
identiﬁed. Here, we report three Type I RM TRS, which
together account for those found in four of the most
clinically important S. aureus and MRSA lineages.
Construction of genetically manipulated strains of clinical
isolates (41,42) belonging to these lineages will now be
possible using vectors constructed without these sites.
The genome location of the Sau1 RM enzymes is also
unusual and bears further investigation. The two hsdM-
hsdS gene pairs are located on genomic islands distant
from each other and distant from the single copy of the
hsdR gene (5,11,15). This arrangement is completely dif-
ferent from arrangement of the hsd genes in the immigra-
tion control region of the archetypal E. coli K12 strain.
Large-scale genome rearrangements have presumably
occurred in S. aureus. The fact that multiple Type I
HsdM and HsdS proteins functionally interact with
Type I HsdR proteins derived from genes in a separate
region of the genome has implications for interpreting
bacterial whole-genome sequences. Multiple hsd genes in
single cells, particularly those that have additional Type I
systems encoded on MGEs, may lead to complex and
highly variable DNA modiﬁcation patterns.
As more and more TRDs of S subunits become
associated with known recognition sequences, then pre-
dicting the TRS in new strains will become a simple
matter of comparing new TRD amino acid sequences
with ones that have known recognition sequences.
Structural modelling of TRDs and their interface with
DNA may become possible and a recognition code
determined for Type I RM enzymes in a manner similar
to that used for the Type II restriction enzyme MmeI and
its relatives (43). Such modelling could use the three
known crystal structures for S subunits (44,45) and the
models of Type I RM enzymes bound to DNA
(13,47,48), though the absence of a crystal structure of a
DNA-S subunit complex might limit the accuracy of such
models. Such modelling would also facilitate the predic-
tion of the adenine methylation sites within the TRS,
something that requires considerable experimental effort
at the moment (24).
RM systems protect host bacteria from foreign DNA
such as bacteriophage. Evidence is accumulating that S.
aureus populations exchange MGE at high frequency, but
this is restricted to isolates from related clones and
lineages (49,50), and here, we show that in clinically im-
portant MRSA isolates, it is controlled by the lineage-
associated Sau1 Type I RM system. Our data suggest
that large conjugative plasmids carrying antibiotic resist-
ance genes have evolved to reduce the number of Type I
RM target recognition sites to enable them to exchange
across lineage barriers. The barrier they evade is speciﬁc-
ally from lineages CC8 and ST239 to lineage CC5. CC5
MRSA is the most prevalent type of hospital MRSA in
the USA. CC8 isolates from the successful community S.
aureus USA300 clone were not originally reported to be
multi-drug resistant but are increasingly found in hospitals
in the USA and increasingly drug resistant (37,40).
Our results strongly indicate that this mechanism of
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restriction evasion may account for the recent reports of
multi-drug resistant plasmid exchange reported between
CC8 and CC5 isolates in the USA (40). The observation
of lower number of restriction enzyme target sites on
MGEs than expected by chance has been known for
many years (51–57), but rarely has this been so clearly
linked to a clinical observation as shown in this work.
The ability to exchange DNA contributes to the success
of MRSA clones in the hospital setting by spreading re-
sistance genes as well as enabling rapid adaptation to
environmental onslaughts (49,50). The avoidance of
TRSs on phage DNA is a well-known mechanism for
evading a host RM system (51–54). This avoidance, par-
ticularly of palindromes, also occurs on the host chromo-
some (53–55). The avoidance of the asymmetric TRS
typical of Type I RM systems is also apparent (56,57),
but no computational study to complement the analysis
of palindromic TRS has been performed to our knowledge
nor has an analysis of avoidance of Type I TRS on
plasmids been published. Thus, our data show that
plasmids, in addition to phage, can evolve to lose RM
target sites for Type I RM systems to spread antibiotic
resistance across restriction boundaries in pathogenic
bacteria. Whole-genome sequencing of large plasmids
from clinically important MRSA is warranted to track
and contain the spread of multi-drug resistant plasmids
amongst high-risk MRSA populations.
Lastly, our results indicate that determining the target
recognition sites for the many Type I RM systems pre-
sent in other pathogens (12) such as H. pylori (22),
N. meningitidis (21) and B. fragilis (23) would be
valuable for understanding the spread of multi-drug resist-
ant plasmids in other organisms. This could be performed
experimentally, but a computational search for the avoid-
ance of the asymmetric target sites typical of Type I RM
systems could also be envisaged.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1 and 2, Supplementary Figures
1–5 and Supplementary Materials and Methods.
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